首页 | 本学科首页   官方微博 | 高级检索  
     


Huntington's disease phenocopies are clinically and genetically heterogeneous
Authors:Edward J. Wild MRCP  Ese E. Mudanohwo BSc  Mary G. Sweeney BSc  Susanne A. Schneider MD  Jon Beck PhD  Kailash P. Bhatia FRCP  MD  Martin N. Rossor FRCP  MD  Mary B. Davis FRCPath  PhD  Sarah J. Tabrizi FRCP  PhD
Affiliation:1. Department of Neurodegenerative Disease, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom;2. Edward J. Wild and Ese E. Mudanohwo contributed equally to this work as first authors.;3. Neurogenetics Unit, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom;4. Sobell Department of Motor Neuroscience and Movement Disorders, UCL Institute of Neurology/National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom
Abstract:Huntington's disease (HD) classically presents with movement disorder, cognitive dysfunction and behavioral problems but is phenotypically variable. One percent of patients with HD‐like symptoms lack the causative mutation and are considered HD phenocopies. Genetic diseases known to cause HD phenocopies include HD‐like syndromes HDL1, HDL2, and HDL4 (SCA17). HD has phenotypic overlap with dentatorubral‐pallidoluysian atrophy, the spinocerebellar ataxias and neuroferritinopathy. Identifying the genetic basis of HD phenocopies is important for diagnosis and may inform the search for HD genetic modifiers. We sought to identify neurogenetic diagnoses in the largest reported cohort of HD phenocopy patients. Two hundred eighty‐five patients with syndromes consistent with HD, who were HD expansion‐negative, were screened for mutations in PRNP, JPH3, TBP, DRPLA, SCA1, SCA2, SCA3, FTL and FRDA. Genetic diagnoses were made in 8 subjects: we identified 5 cases of HDL4, 1 of HDL1 and 1 of HDL2. One patient had Friedreich's ataxia. There were no cases of DRPLA, SCA1, SCA2, SCA3, or neuroferritinopathy. HD phenocopies are clinically and genetically diverse and a definitive genetic diagnosis is currently possible in only a minority of cases. When undertaken, it should be clinically directed and patients and clinicians should be prepared for the low probability of reaching a genetic diagnosis in this group of patients. © 2008 Movement Disorder Society
Keywords:Huntington's disease (HD)  phenocopies  SCA17  familial prion disease  HDL1  HDL2
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号